Linnenbringer Jeanne L. sold $799K of CNO

Linnenbringer Jeanne L. (Chief Operations Officer) sold 14,539 shares of CNO Financial Group, Inc. (CNO) at an average of $54.95 ($54.73–$55.11, $0.80M total) across 4 trades over 2026-08-31 to 2026-09-02 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Linnenbringer Jeanne L.
Published Sep 2, 2026, 8:27 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 2, 2026, 9:48 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$CNO
Neutral
high confidence
Mentioned
$CNO
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CNONeutralLow
01

Why it matters

The disclosed sale is routine and unlikely to move the stock.

02

Market read

Low relevance; typical insider transaction with limited trading implication.

03

What to watch

Potential tax planning or portfolio rebalancing; not a strategic signal.

Relevance 4/10Novelty 4/10Timing: filed 2026-09-02

Background

Form 4 filings disclose insider trades; investors monitor for material changes.

Company-level read

Ticker impact

$CNONeutralHigh confidence
Context

Chief Operations Officer sold $799K of shares via 10b5-1 plan, reducing holdings to 26,209 shares.

Expected impact

No significant price movement expected.

Evidence & confidence

Sale size is small relative to market cap and disclosed under a pre-arranged plan.

Market effects

No broader sector impact; typical insider transaction.

Limited to US financial services sector.

Minimal.

Counterpoint

Insider sell could be interpreted as lack of confidence, but size is trivial.

Key entities

  • Linnenbringer Jeanne L.

    Chief Operations Officer of CNO Financial Group.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CNOMed

CNO Financial Group Inc (CNO) (Q3 2026) Earnings Call Highlights: Raised Guidance

CNO Financial Group reported Q3 2026 earnings, raising guidance. Life NAP decreased 9% due to a discontinued program. Medicare Supplement results were impacted by higher morbidity. Free cash flow guidance tightened to $220-$240M. Net investment income increased 72%, but $12M is not expected to continue. The company discussed reinsurance deals, expense management, and economic pressures. CEO Gary Bhojwani noted structural demand drivers for their services.

$CNOHighAI 8/10

CNO Financial (CNO) Q3 2026 Earnings Call Transcript

CNO Financial reported Q3 2026 earnings, highlighting 4% growth in agent count and strong sales across divisions. Medicare Supplement NAP surged 41%, and Life NAP rose 20% excluding a discontinued program. Annuity premiums increased 9%, and brokerage assets grew 15%. Operating EPS reached $1.90, up 47% YoY. The company ceded $270M in life reserves to CNO Bermuda Re for capital optimization.

$CNOMedAI 8/10

What CNO Financial Group (CNO) Said on Its Q3 Earnings Call

CNO Financial Group reported Q3 operating EPS of $1.42, up 48% YoY. Sales grew in life, hospital indemnity, and accident products. Investment income rose 13%, and the company returned $77M to shareholders. CNO updated its 2026 outlook, lowering the expense ratio and raising EPS estimates. The company also completed a reinsurance transaction with its Bermuda affiliate.